ABBV

ABBVIE INC.
Data: 2026-06-23
$234.76
Price
2.07%
Change
$244.81
52W High
$181.73
52W Low

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Quick Stats
Jun 23, 2026

66.0

AI Score

BUY

1.29

Volume Ratio

Jul 30, 2026

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

ABBV Stock Summary

Last updated Jun 23, 2026

ABBV is currently trading at $234.76, positioned above its 200-day moving average of $220.75, indicating a long-term uptrend. The stock has a 52-week range of $181.73 to $244.81.

Technical Analysis: The 50-day moving average stands at $212.66, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 65.565, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.113, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ABBV at 66.0/100 with a BUY recommendation.

ABBV (ABBVIE INC.) Indicators

Last updated Jun 23, 2026

Indicator Value
RSI(14) 65.565
CMF (20) 0.113
ROC (10) 5.077
ADX (14) 17.276
Indicator Value
MACD (12,26,9) 4.099
AROONOSC (14) 100.0
WILLAMS %R (14) -2.615
MFI (14) 62.049
ABBV Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABBV Price vs Max Options Open Interest
ABBV Max Change In Options Open Interest

ABBV Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABBV Daily Out of Money Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABBV Daily In the Money Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABBV Most Active Options by Volume(near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

ABBVIE INC. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ABBV Moving Averages Analysis

ABBVIE INC. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026

ABBVIE INC. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 23, 2026

ABBV (ABBVIE INC.) Simple Moving Averages

Moving Averages are last updated Jun 23, 2026

Days MA
10 224.94
20 221.75
30 218.03
50 212.66
100 216.57
200 220.75

ABBV Fundamental Analysis

P/E (Forward) 16.129
P/E (Trailing) 112.2
Market Cap ($) 406.4 billion
Earnings/Share ($) 2.05
Net Proft Margin (%) 0.0579
Dividend/Share ($) 6.74
EPS Estimate Current Year ($) 14.2424
EPS Estimate Next Year ($) 16.247
WallStreet Target Price ($) 253.5517
Most Recent Quarter